Filing Details

Accession Number:
0001140361-15-002626
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-01-23 21:44:21
Reporting Period:
2015-01-21
Filing Date:
2015-01-23
Accepted Time:
2015-01-23 21:44:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1416792 Relypsa Inc RLYP Pharmaceutical Preparations (2834) 260893742
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1266163 M Kristine Ball C/O Relypsa, Inc.
700 Saginaw Drive
Redwood City CA 94063
Chief Financial Officer & Svp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-01-21 3,000 $3.96 10,500 No 4 M Direct
Common Stock Disposition 2015-01-21 3,000 $36.00 7,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-01-21 3,000 $0.00 3,000 $3.96
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
125,872 2022-12-04 No 4 M Direct
Footnotes
  1. Includes 7,500 restricted stock units.
  2. The sales reported in this Form 4 were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  3. The shares subject to the option are early exercisable. 25% of the shares subject to the option vest on the first anniversary measured from November 27, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.